As we all know, there are many different methods for the synthesis of a compound, and people can choose the synthesis method that suits their own laboratory according to the actual situation. 57473-32-2, name is 5,7-Dichloroimidazo[1,2-a]pyrimidine, molecular formula is C6H3Cl2N3, The compound is widely used in many fields, so it is necessary to find a new synthetic route. The downstream synthesis method of this compound is introduced below. category: pyrimidines
Example 6: S-^SR^RJ-S-CCT-Chloroimidazotl^-fllpyrimidin-S-yO^ethylJamino)^- methylpiperidin-l-yl)-3-oxopropanenitrile (47)47To a stirred solution of 5,7-dichloroimidazo[l,2-a]pyrimidine (46) (0.082 g, 0.43 mmol) in dioxane (2 niL) was added 3-((3R,4R)-4-methyl-3-(methylamino)piperidin-l-yl)-3- oxopropanenitrile (21) (0.10 g, 0.43 mmol), sodium hydrogen carbonate (0.036 g, 0.43 mmol) and water (2mL). The mixture was subjected microwave irradiation (100 C, Power Max, Power 50w) for 30 minutes. The reaction mixture was concentrated in vacuum and the residue obtained was purified by flash chromatography (silica gel 12 g, eluting with CMA-80 in chloroform 0 to 100%). The product obtained was repurifed by flash chromatography [silica gel 12 g, eluting with a mixture of ethyl acetate and methanol (9:1) in hexanes (0 to 100%)] to afford 3-((3R,4R)-3-((7- Chloroimidazo [ 1 ,2-alpha]pyrimidin-5-yl)(methyl)amino)-4-methylpiperidin- 1 -yl)-3 -oxopropanenitrile (47) (14 mg, 9.38%) as a colorless solid. 1HNMR (300 MHz, DMSO, 380K) delta 7.68 (d, J= 1.6, IH), 7.61 (d, J= 1.6, IH), 6.65 (s, IH), 3.93 (d, J= 5.1, 2H), 3.88 – 3.79 (m, 2H), 3.65 (dd, J= 8.3, 13.7, IH), 3.46 (d, J= 35.6, 2H), 3.00 (s, 3H), 2.32 (d, J= 6.9, IH), 1.80 – 1.58 (m, 2H), 1.03 (d, J= 7.0, 3H); MS (ES+): 347.1 (M + 1), 369.0 (M+23).Compound 46 is commercially available from Toronto Research Chemicals, or it can be prepared as described by, Revankar, Ganapathi R. et al., Journal of Medicinal Chemistry, 1975, 7S(12); or G. R. Revankar and R. K. Robins, Ann. KY. Acad. ScL, 1975, 255, 166.
With the rapid development of chemical substances, we look forward to future research findings about 57473-32-2.
Reference:
Patent; BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; CHAND, Pooran; KOTIAN, Pravin, L.; KUMAR, V., Satish; WO2010/14930; (2010); A2;,
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia